Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|March 7, 2018
Heavy Metal Resistance Genes Are Associated with blaNDM-1- and blaCTX-M-15-Carrying EnterobacteriaceaeQiu E Yang, Siham Rajab Agouri, Jonathan Mark Tyrrell, et al.
Global Challenges (Hoboken, NJ)|October 11, 2021
Measuring Antimicrobial Use Needs Global HarmonizationMuhammad Umair, Mashkoor Mohsin, Ute Wolff Sönksen, et al.
The European Respiratory Journal|April 20, 2019
Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulationJohn Efthimiou, Chris Poll, Peter J Barnes
The Lancet. Infectious Diseases|February 9, 2016
Systematic review of antibiotic resistance in acne: an increasing topical and oral threatTimothy R Walsh, John Efthimiou, Brigitte Dréno
Antimicrobial Agents and Chemotherapy|April 13, 2016
Complete Sequence of the FII Plasmid p42-2, Carrying blaCTX-M-55, oqxAB, fosA3, and floR from Escherichia coliQiu E Yang, Timothy Rutland Walsh, Bao Tao Liu, et al.
Journal of Clinical Pharmacology|April 9, 2002
Bioavailability and metabolism of mometasone furoate: pharmacology versus methodologyHartmut Derendorf, Peter T Daley-Yates, Lisa N Pierre, et al.
Environment International|November 21, 2018
Environmental dissemination of mcr-1 positive Enterobacteriaceae by Chrysomya spp. (common blowfly): An increasing public health riskQiu E Yang, Uttapoln Tansawai, Diego O Andrey, et al.
British Journal of Clinical Pharmacology|June 20, 2017
Comparison of systemic pharmacodynamic effects of two combination pressurized metered dose inhalers that deliver salmeterol and fluticasone propionateLester I Harrison, Victoria Sessions, Christopher J Wiggenhorn, et al.
Frontiers in Global Women'S Health|January 31, 2022
Determinants of Stillbirth From Two Observational Studies Investigating Deliveries in Kano, NigeriaRebecca Milton, Fatima Zara Modibbo, William John Watkins, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2019
A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F ProteinJohn DeVincenzo, Dereck Tait, John Efthimiou, et al.
Pageof 2